Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis.

Jacobson, Ira M

Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis. [electronic resource] - Gastroenterology 05 2017 - 1372-1382.e2 p. digital

Publication Type: Journal Article

1528-0012

10.1053/j.gastro.2017.01.050 doi


Adult
Aged
Aged, 80 and over
Amides
Antiviral Agents--adverse effects
Benzofurans--adverse effects
Carbamates
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Cyclopropanes
Drug Combinations
Drug Resistance, Viral--genetics
Drug Therapy, Combination
Female
Hepacivirus--genetics
Hepatitis C, Chronic--complications
Humans
Imidazoles--adverse effects
Liver Cirrhosis--physiopathology
Male
Middle Aged
Quinoxalines--adverse effects
RNA, Viral--blood
Randomized Controlled Trials as Topic
Retreatment
Retrospective Studies
Ribavirin--therapeutic use
Sulfonamides
Sustained Virologic Response
Viral Nonstructural Proteins--genetics
Young Adult